Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DRNA - Dicerna Pharmaceuticals Inc. (DRNA) CEO Doug Fambrough on Q4 2020 Results - Earnings Call Transcript

DRNA - Dicerna Pharmaceuticals Inc. (DRNA) CEO Doug Fambrough on Q4 2020 Results - Earnings Call Transcript

Dicerna Pharmaceuticals Inc.
Dicerna Pharmaceuticals, Inc. (DRNA) Q4 2020 Earnings Conference Call February 25, 2021 4:30 p.m. ET Company Participants Lauren Stival - Senior Director of IR Doug Fambrough - President and CEO Shreeram Aradhye - Chief Medical Officer Doug Pagan - CFO Jim Weissman - COO Rob Ciappenelli - Chief Commercial Officer Bob Brown - Chief Scientific Officer Conference Call Participants Jonathan Miller - Evercore ISI Brendan Smith - Cowen & Company Rick Bienkowski - SVB Leerink Luca Issi - RBC Capital Stephen Willey - Stifel Nicolaus Ed Arce - H.C. Wainwright & Company Mayank Mamtani - B. Riley Securities Keay Nakae - Chardan Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Dicerna Pharmaceutical's Full-year 2020 Earnings Conference Call. As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Ms. Lauren Stival, Senior Director

For further details see:

Dicerna Pharmaceuticals, Inc. (DRNA) CEO Doug Fambrough on Q4 2020 Results - Earnings Call Transcript
Stock Information
Company Name: Dicerna Pharmaceuticals Inc.
Stock Symbol: DRNA
Market: NASDAQ
Website: dicerna.com
Menu
DRNA DRNA Quote DRNA Short DRNA News DRNA Articles DRNA Message Board
Get DRNA Alerts

News, Short Squeeze, Breakout and More Instantly...